Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care

  • 1Email author,
  • 2,
  • 3,
  • 4,
  • 5 and
  • 6
Critical Care200812:429

https://doi.org/10.1186/cc7031

  • Published:

The original article was published in Critical Care 2007 11:R128

Following the publication of the above article [1], we discovered the omission of the legend from Figures 2 through Figure 5. The following legends should be included for each of these figures:

Figure 2 legend

Model based estimation for mean PCS and standard error bar for all patients. Average group differences: P = 0.04. APC, activated protein C; PCS, physical component score.

Figure 3 legend

Model based estimation for mean RP and standard error bar for all patients. Average group differences: P = 0.10. APC, activated protein C; RP, role physical.

Figure 4 legend

Model based estimation for mean BP and standard error bar for all patients. Average group differences: P = 0.14. APC, activated protein C; BP, bodily pain.

Figure 5 legend

Model based estimation for mean PF and standard error bar for all patients. Average group differences: P = 0.12. APC, activated protein C; PF, physical function.

Notes

Authors’ Affiliations

(1)
McMaster University, Main Street West, Hamilton, Ontario, L8S 4M4, Canada
(2)
Kingston General Hospital, Queen's University, Stuart Street, Kingston, Ontario, K7L 2V7, Canada
(3)
Eli Lilly Canada Inc., Danforth Avenue, Kingston, Ontario Scarborough, M1N 2E8, Canada
(4)
Sunnybrook Health Sciences Centre, Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada
(5)
London Health Sciences Centre, Commissioners Road East, London, Ontario, N6A 5W9, Canada
(6)
Clinical Research Centre, Kingston General Hospital, Stuart Street, Kingston, Ontario, K7L 2V7, Canada

References

  1. Longo CJ, Heyland DK, Fisher HN, Fowler RA, Martin C, Day A: A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care. Crit Care 2007, 11: R128. 10.1186/cc6195PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© BioMed Central Ltd 2008

Advertisement